{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:01:00Z","timestamp":1763017260993},"reference-count":24,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.transci.2013.01.007","type":"journal-article","created":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T16:49:37Z","timestamp":1361206177000},"page":"185-188","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Refractory heparin induced thrombocytopenia with thrombosis (HITT) treated with therapeutic plasma exchange and rituximab as adjuvant therapy"],"prefix":"10.1016","volume":"49","author":[{"given":"Amy M.","family":"Schell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Petras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zbigniew M.","family":"Szczepiorkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah L.","family":"Ornstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.transci.2013.01.007_b0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.hoc.2007.06.004","article-title":"Heparin-induced thrombocytopenia","volume":"21","author":"Warkentin","year":"2007","journal-title":"Hematol Oncol Clin N Am"},{"issue":"6 Suppl","key":"10.1016\/j.transci.2013.01.007_b0010","doi-asserted-by":"crossref","first-page":"340S","DOI":"10.1378\/chest.08-0677","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: american college of chest physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Warkentin","year":"2008","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.transci.2013.01.007_b0015","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/1076029609347900","article-title":"Fondaparinux for the treatment of acute heparin-induced thrombocytopenia: a single-center experience","volume":"16","author":"Grouzi","year":"2010","journal-title":"Clin Appl Thromb Hem"},{"issue":"12","key":"10.1016\/j.transci.2013.01.007_b0020","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1111\/j.1538-7836.2011.04487.x","article-title":"Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30month, 16-patient case series","volume":"9","author":"Warkentin","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.transci.2013.01.007_b0025","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ajh.21939","article-title":"Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders","volume":"86","author":"Dierickx","year":"2011","journal-title":"Am J Hematol"},{"issue":"17","key":"10.1016\/j.transci.2013.01.007_b0030","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM200104263441704","article-title":"Temporal aspects of heparin-induced thrombocytopenia","volume":"344","author":"Warkentin","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.transci.2013.01.007_b0035","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1055\/s-0037-1614218","article-title":"Factor V Leiden and thrombotic complications in heparin-induced thrombocytopenia","volume":"79","author":"Lee","year":"1998","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.transci.2013.01.007_b0040","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/107602960200800406","article-title":"Risk factors and long-term follow-up of patients with the immune type of heparin-induced thrombocytopenia","volume":"8","author":"Lindhoff-Last","year":"2002","journal-title":"Clin Appl Thromb Hem"},{"issue":"5","key":"10.1016\/j.transci.2013.01.007_b0045","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1182\/blood-2011-03-342857","article-title":"Association of natural antiplatelet factor 4\/heparin antibodies with periodontal disease","volume":"118","author":"Greinacher","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.transci.2013.01.007_b0050","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1309\/AJCPG0MNR5NGKNFX","article-title":"Platelet factor 4\/heparin antibodies in blood bank donors","volume":"134","author":"Hursting","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.transci.2013.01.007_b0055","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1213\/ANE.0b013e3181c3c1cd","article-title":"Plasmapheresis and heparin reexposure as a management strategy for cardiac surgical patients with heparin-induced thrombocytopenia","volume":"110","author":"Welsby","year":"2010","journal-title":"Anesth Analg"},{"issue":"4","key":"10.1016\/j.transci.2013.01.007_b0060","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jca.20289","article-title":"Use of plasma exchange in patients with heparin-induced thrombocytopenia: a report of two cases and a review of the literature","volume":"26","author":"Jaben","year":"2011","journal-title":"J Clin Apheresis"},{"issue":"9","key":"10.1016\/j.transci.2013.01.007_b0065","first-page":"1258","article-title":"Treating heparin-induced thrombocytopenia. The unconventional way","volume":"25","author":"Abdel-Razeq","year":"2004","journal-title":"Saudi Med J"},{"issue":"4","key":"10.1016\/j.transci.2013.01.007_b0070","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/jca.20099","article-title":"Salvage late plasmapheresis in a patient with pulmonary embolism caused by heparin-induced thrombocytopenia primarily resistant to danaparoid sodium and lepirudin","volume":"21","author":"Antonijevic","year":"2006","journal-title":"J Clin Apher"},{"issue":"3","key":"10.1016\/j.transci.2013.01.007_b0075","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0049-3848(88)90111-9","article-title":"Treatment of serious heparin-induced thrombocytopenia by plasma exchange: report on 4 cases","volume":"51","author":"Bouvier","year":"1988","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.transci.2013.01.007_b0080","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/ajcp\/96.3.394","article-title":"Plasmapheresis. A therapeutic option in the management of heparin-associated thrombocytopenia with thrombosis","volume":"96","author":"Brady","year":"1991","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"10.1016\/j.transci.2013.01.007_b0085","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/str.21.8.1236b","article-title":"Plasmapheresis in heparin-induced thrombocytopenia and thrombosis","volume":"21","author":"Manzano","year":"1990","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.transci.2013.01.007_b0090","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ajh.2830280318","article-title":"Plasmapheresis in the management of heparin-associated thrombocytopenia with thrombosis","volume":"28","author":"Nand","year":"1988","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.transci.2013.01.007_b0095","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.1365-2141.1998.0847a.x","article-title":"Heparin-induced thrombocytopenia with thrombosis: successful treatment with plasma exchange","volume":"102","author":"Poullin","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2013.01.007_b0100","first-page":"521","article-title":"Plasma exchange and heparin-induced thrombocytopenia","volume":"337","author":"Thorp","year":"1990","journal-title":"Prog Clin Biol Res"},{"issue":"1 Suppl 1","key":"10.1016\/j.transci.2013.01.007_b0105","first-page":"29","article-title":"Plasmapheresis in the management of heparin-induced thrombocytopenia","volume":"36","author":"Robinson","year":"1999","journal-title":"Semin Hematol"},{"issue":"3","key":"10.1016\/j.transci.2013.01.007_b0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jca.20240","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2013evidence-based approach from the apheresis applications committee of the American Society for apheresis","volume":"25","author":"Szczepiorkowski","year":"2010","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.transci.2013.01.007_b0115","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archinte.163.15.1849","article-title":"Argatroban anticoagulation in patients with heparin-induced thrombocytopenia","volume":"163","author":"Lewis","year":"2003","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.transci.2013.01.007_b0120","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1111\/j.1538-7836.2005.01623.x","article-title":"Lepirudin in patients with heparin-induced thrombocytopenia \u2013 results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3","volume":"3","author":"Lubenow","year":"2005","journal-title":"J Thromb Haemost"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050213000232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050213000232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T20:59:30Z","timestamp":1562705970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050213000232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1473050213000232"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2013.01.007","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refractory heparin induced thrombocytopenia with thrombosis (HITT) treated with therapeutic plasma exchange and rituximab as adjuvant therapy","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2013.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}